Aquamarine Financial (Cayman) Ltd
Position in ORMP — Oramed Pharmaceuticals Inc.
CIK 2104187
Grand Cayman, E9
Position in ORMP
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,083,561
+$4,901,701 QoQ
Shares Held
2,512,175
+18.9% QoQ
Ownership
6.04%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#2
of 84 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORMP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aquamarine Financial (Cayman) Ltd holds $21,160,043 across 2 Biotechnology names. ORMP ranks #1 (57.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ORMP |
Oramed Pharmaceuticals Inc.
This page
|
2,512,175 | $12,083,561 | |
| 2 | DRTS |
Alpha Tau Medical Ltd.
|
721,501 | $9,076,482 |
All Filings in ORMP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,083,561 | 2,512,175 | Shares | Sole | 2026-08-12 | |
| 2026-06-30 | $12,083,561 | 2,512,175 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,181,860 | 2,112,312 | Shares | Sole | 2026-05-15 | |
| 2026-01-14 | $7,453,453 | 2,047,652 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,623,212 | 1,973,057 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $5,208,870 | 1,973,057 | Shares | Sole | 2026-01-12 | |
| No filing history on record for this holder in this stock. | ||||||